HW
Therapeutic Areas
Hualan Biological Engineering Pipeline
| Drug | Indication | Phase |
|---|---|---|
| Cell Culture-Based Quadrivalent Influenza Vaccine | Seasonal Influenza Prevention | Phase III |
| 13-valent Pneumococcal Conjugate Vaccine (PCV13) | Pneumococcal Disease Prevention | Phase III |
| Quadrivalent Influenza Vaccine (QIV) | Seasonal Influenza Prevention | Marketed |
| Trivalent Influenza Vaccine (TIV) | Seasonal Influenza Prevention | Marketed |
| Human Albumin | Hypoalbuminemia, Shock, Burns | Marketed |
| Human Immunoglobulin (IVIG) | Primary Immunodeficiency, Autoimmune Disorders | Marketed |
| Human Coagulation Factor VIII | Hemophilia A | Marketed |
| SARS-CoV-2 Inactivated Vaccine | COVID-19 Prevention | Marketed |